JOHN OYLER Insider Trading $BGNE BeiGene, Ltd.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN OYLER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN OYLER. JOHN OYLER is CEO in BeiGene, Ltd. ($BGNE) and Chief Executive Officer in BeiGene, Ltd. ($BGNE).
JOHN OYLER in BeiGene, Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN OYLER: Chief Executive Officer, CEO
Holdings: 7,336,253 shares
Current Value: $263,518,208
Latest Transaction: Dec 15 2020
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN OYLER in BeiGene, Ltd.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2018 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 146.02 | 4,607 | 672,722 | 84,172 | 88.8 K to 84.2 K (-5.19 %) |
| Mar 02 2018 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 144.86 | 5,104 | 739,357 | 88,779 | 93.9 K to 88.8 K (-5.44 %) |
| Mar 02 2018 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 143.48 | 5,117 | 734,187 | 93,883 | 99 K to 93.9 K (-5.17 %) |
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 100.08 | 1,000 | 100,080 | 99,000 | 100 K to 99 K (-1.00 %) |
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 99.05 | 200 | 19,810 | 100,000 | 100.2 K to 100 K (-0.20 %) |
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 97.83 | 1,700 | 166,317 | 100,200 | 101.9 K to 100.2 K (-1.67 %) |
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 96.68 | 8,279 | 800,398 | 101,900 | 110.2 K to 101.9 K (-7.51 %) |
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 95.55 | 8,958 | 855,910 | 110,179 | 119.1 K to 110.2 K (-7.52 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 96.67 | 4,800 | 464,022 | 119,137 | 123.9 K to 119.1 K (-3.87 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 95.62 | 37,208 | 3,557,885 | 123,937 | 161.1 K to 123.9 K (-23.09 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 94.91 | 10,809 | 1,025,851 | 161,145 | 172 K to 161.1 K (-6.29 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 96.66 | 100 | 9,666 | 171,954 | 172.1 K to 172 K (-0.06 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 96.12 | 5,162 | 496,175 | 172,054 | 177.2 K to 172.1 K (-2.91 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 94.98 | 7,743 | 735,434 | 177,216 | 185 K to 177.2 K (-4.19 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 93.94 | 13,213 | 1,241,236 | 184,959 | 198.2 K to 185 K (-6.67 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 93.23 | 9,439 | 880,030 | 198,172 | 207.6 K to 198.2 K (-4.55 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 92.06 | 24,080 | 2,216,764 | 207,611 | 231.7 K to 207.6 K (-10.39 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 93.96 | 1,400 | 131,537 | 231,691 | 233.1 K to 231.7 K (-0.60 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 93.02 | 4,000 | 372,090 | 233,091 | 237.1 K to 233.1 K (-1.69 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 92.36 | 18,046 | 1,666,794 | 237,091 | 255.1 K to 237.1 K (-7.07 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 91.48 | 8,000 | 731,803 | 255,137 | 263.1 K to 255.1 K (-3.04 %) |
| Nov 29 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 82.92 | 36,340 | 3,013,458 | 263,137 | 299.5 K to 263.1 K (-12.13 %) |
| Nov 29 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 85.52 | 32,985 | 2,820,864 | 299,477 | 332.5 K to 299.5 K (-9.92 %) |
| Nov 29 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 87.49 | 235 | 20,560 | 332,462 | 332.7 K to 332.5 K (-0.07 %) |
| Nov 29 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 86.75 | 16,346 | 1,418,022 | 332,697 | 349 K to 332.7 K (-4.68 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 80.84 | 100 | 8,084 | 349,043 | 349.1 K to 349 K (-0.03 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 80.29 | 62,170 | 4,991,791 | 349,143 | 411.3 K to 349.1 K (-15.12 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 79.16 | 3,798 | 300,633 | 411,313 | 415.1 K to 411.3 K (-0.91 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 81.00 | 100 | 8,100 | 415,111 | 415.2 K to 415.1 K (-0.02 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 80.10 | 20,407 | 1,634,501 | 415,211 | 435.6 K to 415.2 K (-4.68 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 79.55 | 39,328 | 3,128,350 | 435,618 | 474.9 K to 435.6 K (-8.28 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 84.04 | 100 | 8,404 | 474,946 | 475 K to 474.9 K (-0.02 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 83.24 | 16,845 | 1,402,136 | 475,046 | 491.9 K to 475 K (-3.42 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 82.67 | 8,109 | 670,376 | 491,891 | 500 K to 491.9 K (-1.62 %) |
| Oct 02 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Option Exercise | A | 7.70 | 935,000 | 7,199,500 | 935,000 | |
| Oct 02 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Grant | A | 0.00 | 515,000 | 0 | 21,745,525 | 21.2 M to 21.7 M (+2.43 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 68.11 | 300 | 20,433 | 0 | 300 to 0 (-100.00 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 67.36 | 3,071 | 206,865 | 300 | 3.4 K to 300 (-91.10 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 66.35 | 51,821 | 3,438,256 | 3,371 | 55.2 K to 3.4 K (-93.89 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 65.42 | 64,553 | 4,222,889 | 55,192 | 119.7 K to 55.2 K (-53.91 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 64.51 | 44,695 | 2,883,234 | 119,745 | 164.4 K to 119.7 K (-27.18 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 63.63 | 30,390 | 1,933,770 | 164,440 | 194.8 K to 164.4 K (-15.60 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 62.57 | 10,324 | 646,015 | 194,830 | 205.2 K to 194.8 K (-5.03 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 61.50 | 6,901 | 424,380 | 205,154 | 212.1 K to 205.2 K (-3.25 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 60.62 | 7,345 | 445,282 | 212,055 | 219.4 K to 212.1 K (-3.35 %) |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 45.73 | 4,500 | 205,786 | 46,840 | 51.3 K to 46.8 K (-8.77 %) |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 44.62 | 10,981 | 490,001 | 51,340 | 62.3 K to 51.3 K (-17.62 %) |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 43.85 | 24,414 | 1,070,566 | 62,321 | 86.7 K to 62.3 K (-28.15 %) |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 44.78 | 1,800 | 80,611 | 86,735 | 88.5 K to 86.7 K (-2.03 %) |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 44.06 | 56,805 | 2,502,658 | 88,535 | 145.3 K to 88.5 K (-39.08 %) |
| May 01 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 42.02 | 2,100 | 88,243 | 145,340 | 147.4 K to 145.3 K (-1.42 %) |
| May 01 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.37 | 34,049 | 1,374,565 | 147,440 | 181.5 K to 147.4 K (-18.76 %) |
| Mar 20 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.02 | 13,234 | 529,611 | 181,489 | 194.7 K to 181.5 K (-6.80 %) |
| Mar 20 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.02 | 2,717 | 108,737 | 194,723 | 197.4 K to 194.7 K (-1.38 %) |
| Mar 20 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 39.37 | 200 | 7,874 | 197,440 | 197.6 K to 197.4 K (-0.10 %) |
| Mar 20 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 38.76 | 15,838 | 613,851 | 197,640 | 213.5 K to 197.6 K (-7.42 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.78 | 4,230 | 172,512 | 213,478 | 217.7 K to 213.5 K (-1.94 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.08 | 15,586 | 624,746 | 217,708 | 233.3 K to 217.7 K (-6.68 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 41.02 | 8,500 | 348,662 | 233,294 | 241.8 K to 233.3 K (-3.52 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.78 | 31,591 | 1,288,306 | 241,794 | 273.4 K to 241.8 K (-11.56 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 41.25 | 49,092 | 2,025,104 | 273,385 | 322.5 K to 273.4 K (-15.22 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.36 | 2,933 | 118,369 | 322,477 | 325.4 K to 322.5 K (-0.90 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 39.83 | 7,426 | 295,794 | 325,410 | 332.8 K to 325.4 K (-2.23 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.67 | 7,204 | 292,981 | 332,836 | 340 K to 332.8 K (-2.12 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.75 | 38,343 | 1,562,489 | 340,040 | 378.4 K to 340 K (-10.13 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.23 | 9,057 | 364,379 | 378,383 | 387.4 K to 378.4 K (-2.34 %) |
| Nov 18 2016 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Option Exercise | A | 2.84 | 2,047,500 | 5,814,900 | 2,047,500 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | OYLER JOHN | CEO | Option Exercise | C | 0.00 | 9,398,380 | 0 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | OYLER JOHN | CEO | Option Exercise | X | 0.00 | 57,777 | 0 | 9,398,380 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | OYLER JOHN | CEO | Option Exercise | X | 0.68 | 57,777 | 38,999 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | OYLER JOHN | CEO | Buy | C | 0.00 | 9,398,380 | 0 | 59,780,349 | 50.4 M to 59.8 M (+18.65 %) |